Congenital erythropoietic porphyria: dilemmas in present day management
Authors:
- 1 November 2002
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 27 (8) , 680-683
Abstract
Congenital erythropoietic porphyria is a rare autosomal recessive disorder of haem biosynthesis caused by a deficiency of uroporphyrinogen III synthetase. There is resultant accumulation and hyperexcretion of porphyrinogens of the isomer I variety. These are converted by spontaneous oxidation into their corresponding photoactive porphyrins leading to photodamage. Accumulation of porphyrins results in haemolysis and extensive photosensitivity. The consequences of chronic haemolysis are splenomegaly, reactive erythroid hyperplasia, erythrodontia, bone fragility, extreme photosensitivity and photomutilation. We present a 35-year-old man who has the severe infantile form and illustrates the haematological and photodestructive complications despite attempts at treatment with hypertransfusion, oral charcoal therapy and beta-carotene. Allogenic bone marrow transplantation has been considered but because of the high associated mortality this procedure has been discounted at present in the management of our patient.Keywords
This publication has 7 references indexed in Scilit:
- Congenital Erythropoietic Porphyria: Prolonged High-Level Expression and Correction of the Heme Biosynthetic Defect by Retroviral-Mediated Gene Transfer into Porphyric and Erythroid CellsMolecular Genetics and Metabolism, 1998
- Congenital erythropoietic porphyriaJournal of the American Academy of Dermatology, 1997
- Lack of Effect of Oral Charcoal in Congenital Erythropoietic PorphyriaNew England Journal of Medicine, 1994
- Bone-marrow transplantation for congenital erythropoietic porphyriaThe Lancet, 1991
- The osteodystrophy of congenital erythropoietic porphyriaBone, 1991
- Complete Suppression of the Symptoms of Congenital Erythropoietic Porphyria by Long-Term Treatment with High-Level TransfusionsNew England Journal of Medicine, 1986
- Beta-Carotene as a Photoprotective Agent in Erythropoietic ProtoporphyriaNew England Journal of Medicine, 1970